Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China flag China · Delayed Price · Currency is CNY
8.62
-0.11 (-1.26%)
Sep 2, 2026, 3:04 PM CST

SHE:002873 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
8.219.1152.3280.87111.52100.61
Depreciation & Amortization
38.1537.6837.3823.3425.4522.81
Other Amortization
5.066.81.611.471.282.69
Loss (Gain) From Sale of Assets
-0.060.78-18.9-0.020.1
Asset Writedown & Restructuring Costs
-0.320.160.710.070.120.37
Loss (Gain) From Sale of Investments
-0.090.02-0.020.720.4-
Provision & Write-off of Bad Debts
-1.38-1.382.61-0.270.521.73
Other Operating Activities
21.3721.4223.3316.1115.2317.52
Change in Accounts Receivable
92.0149.95-38.037-20.18-8.45
Change in Inventory
-9.76-30.2335.8-1.2-66.75-40.35
Change in Accounts Payable
-28.14-11.11-10-52.081.7925.94
Operating Cash Flow
126.5983.7388.1377.7875.82124.3
Operating Cash Flow Growth
3.04%-4.99%13.30%2.59%-39.00%-29.28%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-69.59-51.59-61.45-101.7-129.2-105.69
Sale of Property, Plant & Equipment
0.282.1415.0850.030.08
Cash Acquisitions
-7.4-2.99----
Investment in Securities
-40-400050-112
Other Investing Activities
-0.01----
Investing Cash Flow
-116.71-92.43-46.37-96.7-79.17-217.61

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-532.75680506347273
Total Debt Issued
401.21532.75680506347273
Long-Term Debt Repaid
--421.63-577.29-404-278-418.63
Total Debt Repaid
-317.13-421.63-577.29-404-278-418.63
Net Debt Issued (Repaid)
84.08111.12102.7110269-145.63
Issuance of Common Stock
24.56----27.81
Repurchase of Common Stock
-5.44-5.44-129.48-2.99-3.1-15.02
Common Dividends Paid
-25.24-41.42-35.06-42.53-34.35-30.33
Other Financing Activities
0.11-----1.12
Financing Cash Flow
78.0764.25-61.8356.4831.54-164.3

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
---0--
Net Cash Flow
87.9555.56-20.0737.5728.19-257.61

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
5732.1426.68-23.92-53.3818.61
Free Cash Flow Growth
-28.83%20.48%----82.71%
Free Cash Flow Margin
7.88%4.29%3.11%-2.51%-4.91%1.92%
Free Cash Flow Per Share
0.250.140.12-0.10-0.220.08
Levered Free Cash Flow
57.65.56-6.5-31.37-97.92-17.28
Unlevered Free Cash Flow
68.716.664.48-23.99-91.24-6.9

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
80.2886.3379.8697.63117.84112
Change in Working Capital
55.669.15-10.9-44.54-78.71-21.52